Literature DB >> 1319008

Effects of cocaine and pimozide on plasma and brain alpha-melanocyte-stimulating hormone levels in rats.

Z Sarnyai1, M Vecsernyés, J Julesz, G Szabó, G Telegdy.   

Abstract

The effects of cocaine on rat plasma and brain alpha-melanocyte-stimulating hormone (alpha-MSH) levels have been studied by means of a specific radioimmunoassay. The selected brain areas were the hypothalamus, septum-nucleus accumbens and hippocampus. Cocaine given subcutaneously decreased the alpha-MSH levels in the peripheral blood. Pimozide, a dopaminergic antagonist, had an opposite effect: it increased the alpha-MSH levels in the peripheral blood. Combined treatment with cocaine + pimozide resulted in a decrease in the pimozide-induced increase in alpha-MSH levels in the blood. Cocaine and pimozide or the combination of cocaine + pimozide were ineffective on the alpha-MSH levels in the hypothalamus and septum-accumbens brain regions. In the hippocampus, cocaine in the dose applied induced a slight but not significant decrease in the alpha-MSH level. Pimozide caused a significant decrease in the hippocampal alpha-MSH level which disappeared at 60 min. Cocaine prevented the pimozide-induced depletion of alpha-MSH. The data indicate that cocaine may act as a dopaminergic agonist in the mechanism of control of alpha-MSH secretion from the intermediate lobe of the pituitary. The alpha-MSH levels in the brain are controlled by different mechanisms. In some brain areas, the dopaminergic system has no action; in others the mechanisms might be similar to but slightly different from that in the pituitary.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319008     DOI: 10.1159/000126090

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  4 in total

1.  Blockade of melanocortin transmission inhibits cocaine reward.

Authors:  Richard Hsu; Jane R Taylor; Samuel S Newton; John D Alvaro; Colin Haile; G Han; Victor J Hruby; Eric J Nestler; Ronald S Duman
Journal:  Eur J Neurosci       Date:  2005-04       Impact factor: 3.386

2.  Inter-individual variability amplified through breeding reveals control of reward-related action strategies by Melanocortin-4 Receptor in the dorsomedial striatum.

Authors:  Aylet T Allen; Elizabeth C Heaton; Lauren P Shapiro; Laura M Butkovich; Sophie T Yount; Rachel A Davies; Dan C Li; Andrew M Swanson; Shannon L Gourley
Journal:  Commun Biol       Date:  2022-02-08

3.  Pro-opiomelanocortin modulates the thermogenic and physical activity responses to high-fat feeding and markedly influences dietary fat preference.

Authors:  Y C Loraine Tung; Debra Rimmington; Stephen O'Rahilly; Anthony P Coll
Journal:  Endocrinology       Date:  2007-08-23       Impact factor: 4.736

Review 4.  Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.

Authors:  Willem Johan van den Brink; Semra Palic; Isabelle Köhler; Elizabeth Cunera Maria de Lange
Journal:  Pharm Res       Date:  2018-02-15       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.